China (Mainland)
Diamondsupplier 
Ganirelix Acetate CAS 123246-29-7 CAS NO.123246-29-7
- Min.Order: 10 Milligram
- Payment Terms: L/C,D/A,D/P,T/T
- Available Specifications:
- Product Details
Keywords
- Ganirelix
- Ganirelix Acetate
- 123246-29-7
Quick Details
- ProName: Ganirelix Acetate CAS 123246-29-7
- CasNo: 123246-29-7
- Molecular Formula: C80h113cln18o13
- Appearance: white powder
- Application: Ganirelix Acetate
- DeliveryTime: 5 days
- PackAge: Vial or customized
- Port: Shanghai, Beijing, Shenzhen etc.
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: 2-8℃ sealed and away from light
- Transportation: Ocean and air shipping
- LimitNum: 10 Milligram
- Related Substances: Effective ingredients >99%
- Residue on Ignition: 0.1
- Heavy Metal: 0
- Valid Period: 3 years
Superiority
GMP Manafacturer
High Purity
Competitive Price
Short Delivery Time
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Details
Ganirelix acetate CAS No. 123246-29-7
Ganirelix acetate is a synthetic decapeptide with high antagonist activity and the first GnRH antagonist to be marketed. It is approved for the suppression of LH surges in women who are undergoing ovarian hyperstimulation fertility treatment.
| Product Name | Ganirelix Acetate |
| CAS NO. | 123246-29-7 |
| Appearance | White Powder/ Freeze-Dried Powder |
| Purity | 99% or customized |
| Application | Drug peptides |
| Usage | Ganirelix is a synthetic decapeptide with high antagonist activity and the first GnRH antagonist to be marketed. |
Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.